7-Jan-2025
Liver protein SerpinA1 enhances fat browning and glucose control
Kumamoto UniversityPeer-Reviewed Publication
Researchers from Kumamoto University have identified a liver-derived protein, serine protease inhibitor A1 (SerpinA1), as a key regulator in combating obesity and enhancing glucose metabolism. This groundbreaking study, published in Nature Communications, sheds light on how activating brown adipose tissue (BAT) could pave the way for innovative treatments for diabetes and metabolic disorders.
- Journal
- Nature Communications
- Funder
- Japan Society for the Promotion of Science, Japan Association for Diabetes Education and Care, Kumamoto University Hospital Research Revitalization Project (2023), Manpei Suzuki Diabetes Foundation, Japan Society for the Study ofObesity, Novo Nordisk Pharma, Astellas Foundation for Research on Metabolic Disorders, Center for Metabolic Regulation of Healthy Aging, Japan Agency for Medical Research and Development, Japan Foundation for Applied Enzymology, NIH grant